5-chloro-3-methyl-2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide | 31363-85-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻二嗪
• 英文名称: 5-chloro-3-methyl-2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide
• 英文别名: 124-Benzthiadiazin-1-O2-3-ME-5-CL；5-chloro-3-methyl-4H-1λ6,2,4-benzothiadiazine 1,1-dioxide
• CAS: 31363-85-6
• 化学式: C₈H₇ClN₂O₂S
• 分子量: 230.675
• InChiKey: RTODZWQEQHFRAB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  14
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  66.9
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• PROCESS TO ACTIVATE EXTRACTS DERIVED FROM LIVING ORGANISMS USING LONG WAVE UV IRRADIATION AND COMPOSITIONS COMPRISING SAID ACTIVATED EXTRACT
  申请人：Gruber Florian

  公开号：US20100119613A1

  公开（公告）日：2010-05-13

  The present invention relates to a method for producing an extract which is capable of inducing an antioxidant stress response comprising the step of treating an extract from organic material with UV light, said extract being derived from a non-mammalian cell or a non-mammalian organism and said cell or organism being capable of synthesizing polyunsaturated fatty acids. Furthermore, an extract capable of inducing an antioxidant stress response produced in accordance with the inventive methods, in particular an extract capable of inducing an antioxidant stress response for the preparation of a cosmetic composition is disclosed. The present invention also relates to a cosmetic composition comprising the inventive extract obtainable by the method provided herein.
• [EN] NOVEL CYCLOPENT-2-EN-1-ONE DERIVATIVES WHICH ARE PPAR RECEPTOR MODULATORS, AND USE THEREOF IN PHARMACEUTICAL OR COSMETIC COMPOSITIONS<br/>[FR] NOUVEAUX DERIVES DE CYCLOPENT-2-EN-1-ONE QUI SONT DES MODULATEURS DE RECEPTEURS PPAR ET LEUR UTILISATION DANS DES COMPOSITIONS PHARMACEUTIQUES OU COSMETIQUES
  申请人：GALDERMA RES & DEV

  公开号：WO2007029121A2

  公开（公告）日：2007-03-15

  (EN) The invention relates to novel compounds which correspond to general formula (I) below: and also to the method for preparing them, and to their use in pharmaceutical compositions for use in human or veterinary medicine, in particular in dermatology, and also in the field of cardiovascular diseases, immune diseases and/or diseases related to lipid metabolism, or alternatively in cosmetic compositions.(FR) L'invention concerne de nouveaux composés qui correspondent à la formule générale (I) ci-dessous ainsi qu'un procédé de leur préparation et de leur utilisation dans des compositions pharmaceutiques ou vétérinaires, notamment en dermatologie, ainsi que dans le domaine des maladies cardio-vasculaires, des maladies immunitaires et/ou des maladies liées au métabolisme lipidique, ou en variante dans des compositions cosmétiques.